Category:
Drugstores
Region:
USA
|
|
20 TRUTHS, MYTHS ABOUT PRESCRIPTION DRUGS
Source: Bellingham Herald
Date: 7-May-2012
Author: TAIMI DUNN GORMAN
Pharmacist Robin Johansen is the fourth in a line of Fairhaven Pharmacy delivery boys who grew up to own the business.
Full text
|
|
Category:
Drugs Prices
Region:
Canada
|
|
EU DEAL COULD BRING DRUG PRICE HIKE
Source: Vancouver Sun
Date: 4-May-2012
Author: Peter O'Neil
Provinces fear a sharp rise in the price of prescription drugs if the Harper government accepts European Union demands to expand patent protection for drugs.
Full text
|
|
Category:
Business
Region:
United Kingdom
|
|
GENERIC DRUG MARKET TO GROW TO $221 BILLION BY 2016
Source: Healthcare Packaging
Date: 1-May-2012
U.K.-based firm notes the economic recession was a double-edged sword for the international generics drug business.
Full text
|
|
Category:
Drugs Prices
Region:
India
|
|
WILL INDIA CONTINUE TO SUPPLY CHEAP DRUGS?
Source: Deccan Herald
Date: 26-Apr-2012
Author: Martin Khor
India may be famous for the Taj Mahal, its religious ceremonies, Bollywood films and one of the highest economic growth rates in recent years. But more importantly, India has had a positive global impact through its supply of vast quantities of low-cost, good-quality generic medicines, which have saved or prolonged millions of lives. Many people go to India to buy life-saving generic medicines from pharmacies and bring these back in suitcases to give to close relatives who cannot afford the expensive branded original products.
Full text
|
|
Category:
Law suits
Region:
USA
|
|
PATENTS, PATIENTS, AND PROFITS: WINNERS AND LOSERS IN DRUG PATENT CHALLENGES
Source: RegBlog
Date: 23-Apr-2012
Author: Bhaven Sampat
Balancing incentives for innovation and access to medicines is the central policy challenge for pharmaceuticals. The United States, like other industrialized countries, achieves this balance via patents. Patents give branded drug makers the right, for a limited time, to exclude generic firms from the market. Competition from generics after this period generally leads to lower drug costs and improved access to medicines.
Full text
|
|
|
Next page >>
|
